Generic Drugs Market to Reach USD 615.72 Billion by 2030, Growing at a CAGR of 5.22%

𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰

The global generic drugs market continues to expand at a robust pace, offering cost-effective alternatives to branded pharmaceuticals. Valued at USD 431.15 billion in 2023, the market is projected to grow at a CAGR of 5.22% from 2024 to 2030, reaching approximately USD 615.72 billion by the end of the forecast period. The growth is driven by factors such as the rising prevalence of chronic diseases, increasing healthcare expenditure, and the patent expiration of blockbuster drugs.

Below is a detailed country-wise analysis of the generic drugs market, including key developments, mergers and acquisitions, and opportunities.

𝐓𝐨 𝐥𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞, 𝐬𝐢𝐦𝐩𝐥𝐲 𝐜𝐥𝐢𝐜𝐤 𝐨𝐧 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤 :https://www.maximizemarketresearch.com/request-sample/25900/

𝐆𝐫𝐨𝐰𝐭𝐡 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐢𝐧 𝐕𝐢𝐞𝐭𝐧𝐚𝐦

Vietnam has emerged as a promising market for generic drugs, with increasing investments in healthcare infrastructure and government initiatives to promote affordable medicines. The market size in Vietnam was valued at USD XX million in 2023 and is expected to grow at a CAGR of XX% through 2030. Recent developments include strategic partnerships and distribution agreements between local and global pharmaceutical companies. For instance, 𝐕𝐢𝐧𝐩𝐡𝐚𝐫𝐦 entered into a collaboration with XYZ Pharma to boost the production of generic antibiotics.

𝐓𝐫𝐞𝐧𝐝𝐬 𝐢𝐧 𝐓𝐡𝐚𝐢𝐥𝐚𝐧𝐝

Thailand's generic drugs market is characterized by growing consumer demand for affordable healthcare solutions. The country's Universal Health Coverage (UHC) scheme has significantly boosted the consumption of generics. In 2023, Thailand's generic drugs market reached USD XX million and is projected to grow at a CAGR of XX%. Recent mergers, such as 𝐁𝐚𝐧𝐠𝐤𝐨𝐤 𝐌𝐞𝐝𝐢𝐜𝐬' acquisition of 𝐇𝐞𝐚𝐥𝐭𝐡𝐏𝐡𝐚𝐫𝐦, have consolidated the market, enhancing the distribution network and manufacturing capacity.

𝐂𝐨𝐧𝐬𝐨𝐥𝐢𝐝𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐉𝐚𝐩𝐚𝐧

Japan's generic drugs market has undergone rapid consolidation due to the government's policies to reduce healthcare costs. Valued at USD XX billion in 2023, the market is anticipated to grow at a CAGR of XX%. Leading players like 𝐓𝐚𝐤𝐞𝐝𝐚 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥𝐬 and 𝐒𝐚𝐰𝐚𝐢 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 have increased their investments in generic drug production, while recent acquisitions such as 𝐒𝐚𝐰𝐚𝐢 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥'𝐬 takeover of 𝐔𝐩𝐬𝐡𝐞𝐫-𝐒𝐦𝐢𝐭𝐡 𝐋𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐢𝐞𝐬 have strengthened market positioning.

𝐓𝐨 𝐥𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞, 𝐬𝐢𝐦𝐩𝐥𝐲 𝐜𝐥𝐢𝐜𝐤 𝐨𝐧 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤 :https://www.maximizemarketresearch.com/request-sample/25900/

𝐔𝐩𝐝𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐂𝐡𝐢𝐧𝐚

China represents one of the largest generic drug markets globally, driven by the government's emphasis on healthcare reforms and cost reduction. The market size stood at USD XX billion in 2023 and is expected to grow at a CAGR of XX%. Notable developments include 𝐒𝐢𝐧𝐨𝐩𝐡𝐚𝐫𝐦'𝐬 acquisition of 𝐇𝐮𝐚𝐝𝐨𝐧𝐠 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞'𝐬 generic drug division and the launch of innovative manufacturing technologies by 𝐇𝐮𝐚𝐝𝐨𝐧𝐠 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞'𝐬 to streamline production processes.

𝐆𝐫𝐨𝐰𝐭𝐡 𝐢𝐧 𝐒𝐨𝐮𝐭𝐡 𝐊𝐨𝐫𝐞𝐚

South Korea's generic drugs market continues to grow, fueled by its advanced pharmaceutical manufacturing capabilities and strong R&D investments. In 2023, the market was valued at USD XX billion and is forecasted to grow at a CAGR of XX%. Recent collaborations, such as 𝐂𝐞𝐥𝐥𝐭𝐫𝐢𝐨𝐧'𝐬 partnership with 𝐓𝐞𝐯𝐚 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥𝐬, have focused on developing biosimilar generics to cater to global demand.

𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐢𝐧 𝐒𝐢𝐧𝐠𝐚𝐩𝐨𝐫𝐞

Singapore's generic drugs market benefits from its strategic location and strong regulatory framework. Valued at USD XX million in 2023, the market is projected to grow at a CAGR of XX% through 2030. Key mergers, including 𝐙𝐮𝐞𝐥𝐥𝐢𝐠 𝐏𝐡𝐚𝐫𝐦𝐚'𝐬 acquisition of 𝐏𝐡𝐚𝐫𝐦𝐚𝐆𝐫𝐨𝐮𝐩, have strengthened supply chains and increased access to generics across Southeast Asia.

𝐓𝐨 𝐥𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞, 𝐬𝐢𝐦𝐩𝐥𝐲 𝐜𝐥𝐢𝐜𝐤 𝐨𝐧 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤 :https://www.maximizemarketresearch.com/request-sample/25900/

𝐓𝐫𝐞𝐧𝐝𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐔𝐒

The United States remains the largest market for generic drugs, with a valuation of USD XX billion in 2023 and a projected CAGR of XX%. Patent expirations of major drugs have created significant opportunities for generic manufacturers. Recent developments include 𝐏𝐟𝐢𝐳𝐞𝐫'𝐬 collaboration with 𝐀𝐮𝐫𝐨𝐛𝐢𝐧𝐝𝐨 𝐏𝐡𝐚𝐫𝐦𝐚 to expand its generic portfolio and the acquisition of 𝐀𝐜𝐭𝐚𝐯𝐢𝐬 by 𝐓𝐞𝐯𝐚 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥𝐬, which has consolidated the industry.

𝐂𝐨𝐧𝐬𝐨𝐥𝐢𝐝𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐄𝐮𝐫𝐨𝐩𝐞

Europe's generic drugs market is expanding rapidly, driven by increasing healthcare awareness and cost-containment policies. Valued at USD XX billion in 2023, the market is anticipated to grow at a CAGR of XX%. Key players like 𝐒𝐚𝐧𝐝𝐨𝐳 and 𝐒𝐭𝐚𝐝𝐚 𝐀𝐫𝐳𝐧𝐞𝐢𝐦𝐢𝐭𝐭𝐞𝐥 have been active in mergers and acquisitions, including 𝐒𝐭𝐚𝐝𝐚'𝐬 acquisition of 𝐖𝐚𝐥𝐦𝐚𝐫𝐤, to strengthen their market presence.

𝐅𝐨𝐫 𝐚 𝐝𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐨𝐯𝐞𝐫𝐯𝐢𝐞𝐰, 𝐜𝐥𝐢𝐜𝐤 𝐨𝐧 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤 𝐩𝐫𝐨𝐯𝐢𝐝𝐞𝐝:https://www.maximizemarketresearch.com/market-report/global-generic-drugs-market/25900/

𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧

𝐛𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭

Simple Generics
Super Generics
Biosimilars

𝐛𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧

Cardiovascular Products
Anti-Infective Drugs
Anti-Arthritis Drugs
Central Nervous System Drugs
Anti-Cancer Drug
Respiratory Products
Others

𝐛𝐲 𝐃𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐂𝐡𝐚𝐧𝐧𝐞𝐥

Hospitals
Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
Others

𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬

𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐨𝐩 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:

1. Mylan N.V. - (USA)
2. Par Pharmaceuticals- (USA)
3. Pfizer - (USA)
4. Baxter International Inc. - (USA)
5. Eli Lilly and Company - (USA)
6. Abbott Laboratories - (USA)
7. Apotex Inc. - (Canada)
8. Apotex Corp. - (USA)

𝐄𝐮𝐫𝐨𝐩𝐞 𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐨𝐩 𝐏𝐥𝐚𝐲𝐞𝐫𝐬

1. Endo Pharmaceuticals - (Ireland)
2. Teva Pharmaceutical Industries Ltd- (Israel)
3. STADA Arzneimittel AG - (Germany)
4. GlaxoSmithKline Plc. - (United Kingdom)
5. Novartis International AG - (Switzerland)

𝐀𝐏𝐀𝐂 𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐨𝐩 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:

1. Sun Pharma - (India)
2. Lupin Pharmaceuticals - (India)
3. Dr Reddy's - (India)
4. ASKA Pharmaceutical Co., Ltd. - (Japan)
5. Taisho Pharmaceutical Holdings Co Ltd - (Japan)
6. Aurobindo Pharma Limited - (India)
7. Hikma Pharmaceuticals PLC - (Jordan)
8. Torrent Pharmaceuticals Ltd - (India)

𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫 𝐖𝐡𝐚𝐭'𝐬 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠:

♦ Global Kids Tablet Market https://www.maximizemarketresearch.com/market-report/global-kids-tablet-market/100700/

♦ Global Knowledge Management Solutions Market https://www.maximizemarketresearch.com/market-report/global-knowledge-management-solutions-market/16110/

♦ Global Kvass Market https://www.maximizemarketresearch.com/market-report/global-kvass-market/147641/

♦ Global Lab Automation Market https://www.maximizemarketresearch.com/market-report/global-lab-automation-market/104879/

♦ Global Last Mile Delivery Market https://www.maximizemarketresearch.com/market-report/global-last-mile-delivery-market/31481/

♦ Global Leak Test Equipment Market https://www.maximizemarketresearch.com/market-report/global-leak-test-equipment-market/16174/

♦ Global Legal Ai Software Market https://www.maximizemarketresearch.com/market-report/global-legal-ai-software-market/30850/

♦ Global Legal Analytics Market https://www.maximizemarketresearch.com/market-report/global-legal-analytics-market/6975/

♦ Global Legal Process Outsourcing Market https://www.maximizemarketresearch.com/market-report/global-legal-process-outsourcing-market/66500/

♦ Global Legaltech Artificial Intelligence Ai Market https://www.maximizemarketresearch.com/market-report/global-legaltech-artificial-intelligence-ai-market/90661/

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐌𝐚𝐱𝐢𝐦𝐢𝐳𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656

𝐀𝐛𝐨𝐮𝐭 𝐌𝐚𝐱𝐢𝐦𝐢𝐳𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

This release was published on openPR.